The shares of Western Digital Corporation have increased by more than 50.39% this year alone. The shares recently went up by 2.64% or $1.43 and now trades at $55.60. The shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), has slumped by -64.93% year to date as of 08/13/2019. The shares currently trade at $2.83 and have been able to report a change of -4.71% over the past one week.

The stock of Western Digital Corporation and BioCryst Pharmaceuticals, Inc. were two of the most active stocks on Tuesday. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? We will analyze the growth, profitability, risk, valuation, and insider trends of both companies and see which one investors prefer.

**Next 5Y EPS Growth: -13.80% versus 19.90%**

When a company is able to grow consistently in terms of earnings at a high compound rate have the highest likelihood of creating value for its shareholders over time. Analysts have predicted that WDC will grow it’s earning at a -13.80% annual rate in the next 5 years. This is in contrast to BCRX which will have a positive growth at a 19.90% annual rate. This means that the higher growth rate of BCRX implies a greater potential for capital appreciation over the years.

**Profitability and Returns**

Growth alone cannot be used to see if the company will be valuable. Shareholders will be the losers if a company invest in ventures that aren’t profitable enough to support upbeat growth. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure. WDC has an EBITDA margin of 18.32%, this implies that the underlying business of WDC is more profitable. The ROI of WDC is 16.40% while that of BCRX is -84.90%. These figures suggest that WDC ventures generate a higher ROI than that of BCRX.

**Cash Flow**

The value of a stock is ultimately determined by the amount of cash flow that the investors have available. Over the last 12 months, WDC’s free cash flow per share is a negative -0.07, while that of BCRX is also a negative -0.12.

**Liquidity and Financial Risk**

The ability of a company to meet up with its short-term obligations and be able to clear its longer-term debts is measured using Liquidity and leverage ratios. The current ratio for WDC is 2.10 and that of BCRX is 1.80. This implies that it is easier for WDC to cover its immediate obligations over the next 12 months than BCRX. The debt ratio of WDC is 1.04 compared to 3.68 for BCRX. BCRX can be able to settle its long-term debts and thus is a lower financial risk than WDC.

**Valuation**

WDC currently trades at a forward P/E of 8.34, a P/B of 1.59, and a P/S of 1.00 while BCRX trades at a P/B of 14.15, and a P/S of 14.35. This means that looking at the earnings, book values and sales basis, WDC is the cheaper one. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.

**Analyst Price Targets and Opinions**

The mistake some people make is that they think a cheap stock has more value to it. In order to know the value of a stock, there is need to compare its current price to its likely trading price in the future. The price of WDC is currently at a -5.6% to its one-year price target of 58.90. Looking at its rival pricing, BCRX is at a -63.99% relative to its price target of 7.86.

When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), WDC is given a 2.60 while 2.30 placed for BCRX. This means that analysts are more bullish on the outlook for WDC stocks.

**Insider Activity and Investor Sentiment**

Short interest or otherwise called the percentage of a stock’s tradable shares currently being shorted is another data that investors use to get a handle on sentiment. The short ratio for WDC is 3.41 while that of BCRX is just 5.47. This means that analysts are more bullish on the forecast for WDC stock.

Conclusion

The stock of BioCryst Pharmaceuticals, Inc. defeats that of Western Digital Corporation when the two are compared, with BCRX taking 4 out of the total factors that were been considered. BCRX happens to be more profitable, generates a higher ROI, has higher cash flow per share, higher liquidity and has a lower financial risk. When looking at the stock valuation, BCRX is the cheaper one on an earnings, book value and sales basis. Finally, the sentiment signal for BCRX is better on when it is viewed on short interest.